publication date: Apr. 18, 2014

Funding Opportunity
Defense Department Offering $30.5 Mil In Research Grants

The Department of Defense announced the availability of several grants through its Ovarian Cancer Research Program and its Lung Cancer Research Program.

The program is offering a total of $20 million to support ovarian cancer research and $10.5 million for lung cancer research, both administered by the U.S. Army Medical Research and Materiel Command through the Office of Congressionally Directed Medical Research Programs.

The grants include funding positions at a virtual ovarian cancer academy, including 10-12 early-career investigators, their mentors, a dean and an assistant dean.

Program announcements and general application instructions are available on the Grants.gov website.


The Clinical Translational Leverage Award
offers a maximum of $250,000 in funding for direct costs, plus indirect costs, for an independent investigator at or above the level of assistant professor. The award supports leveraging of human-based ovarian cancer resources in translational research to address high-impact research or unmet needs in ovarian cancer. Early-stage clinical trials are allowed, with cost sharing required for applications including a clinical trial. Pre-applications are due June 3. Full applications are by invitation only, and are due Aug. 27.

The Investigator-Initiated Research Award offers a maximum of $450,000 in funding for direct costs in support of meritorious basic and clinically oriented research in ovarian cancer, with impact as an important review criterion. Applicants must be an independent investigator at or above the level of assistant professor. Clinical trials are not allowed and preliminary data are required. Pre-applications are due June 3. Full applications are by invitation only, and are due Aug. 27.

Continue reading 40-16 Funding Opportunity

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.